HANCOCK WHITNEY CORP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 103 filers reported holding IMMUNOMEDICS INC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
HANCOCK WHITNEY CORP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2017$233,000
+36.3%
26,4000.0%0.01%
+42.9%
Q1 2017$171,000
+76.3%
26,4000.0%0.01%
+75.0%
Q4 2016$97,000
+12.8%
26,4000.0%0.00%
+33.3%
Q3 2016$86,000
+41.0%
26,4000.0%0.00%0.0%
Q2 2016$61,000
-7.6%
26,4000.0%0.00%0.0%
Q1 2016$66,000
-18.5%
26,4000.0%0.00%0.0%
Q4 2015$81,000
+80.0%
26,4000.0%0.00%
+50.0%
Q3 2015$45,000
-55.4%
26,4000.0%0.00%
-50.0%
Q2 2015$101,0000.0%26,4000.0%0.00%0.0%
Q1 2015$101,000
-20.5%
26,4000.0%0.00%
-20.0%
Q4 2014$127,000
+29.6%
26,4000.0%0.01%
+25.0%
Q3 2014$98,000
+2.1%
26,4000.0%0.00%
+33.3%
Q2 2014$96,000
-13.5%
26,4000.0%0.00%
-25.0%
Q1 2014$111,000
-8.3%
26,4000.0%0.00%
-20.0%
Q4 2013$121,000
-26.2%
26,4000.0%0.01%
-37.5%
Q3 2013$164,000
+13.9%
26,4000.0%0.01%
+14.3%
Q2 2013$144,00026,4000.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,711,067$2,943,0001.70%
J.P. Turner & Co Capital Mnagement, LLC 248,625$428,0000.44%
Orbimed Advisors 3,323,000$5,716,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 2,004,078$3,447,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 5,870$1,018,0000.02%
SIGNET FINANCIAL MANAGEMENT, LLC 44,675$77,0000.02%
SVB WEALTH LLC 195,000$335,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 288,900$497,0000.01%
J.P. Turner & Co Capital Mnagement, LLC 153,900$8,0000.01%
BALYASNY ASSET MANAGEMENT L.P. 640,400$1,101,0000.01%
View complete list of IMMUNOMEDICS INC shareholders